Neuropharmacology of anxiety: perspectives and prospects
- 1 February 1994
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 15 (2) , 36-39
- https://doi.org/10.1016/0165-6147(94)90104-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- CCK in animal and human research on anxietyTrends in Pharmacological Sciences, 1993
- Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-mazePsychopharmacology, 1992
- Buspirone impairs performance of a three-choice working memory water escape task in ratsBrain Research Bulletin, 1992
- S 14506: A novel, potent, high‐efficacy 5‐HT1A agonist and potential anxiolytic agentDrug Development Research, 1992
- S 14671: A novel naphthylpiperazane 5-HT1A agonist of high efficacy and exceptional in vivo potencyEuropean Journal of Pharmacology, 1991
- The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypotalamo-pituitary-adrenal axesEuropean Journal of Pharmacology, 1991
- Effects of HA‐966 on conflict, social interaction, and plus maze behaviorsDrug Development Research, 1991
- Pharmacological and Behavioral Profile of Alpidem as an AnxiolyticPharmacopsychiatry, 1990
- CO2 vulnerability in panic disorderPsychiatry Research, 1987
- Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasksNature, 1986